Callan JMB Inc. provides integrative logistics services for healthcare organizations and emergency management agencies, including fulfillment, storage, monitoring, cold-chain logistics and specialized distribution. Company updates commonly address emergency preparedness contracts, reverse distribution of vaccines and pharmaceuticals, regulated product handling, government relationships and business updates tied to healthcare supply-chain resilience.
Recurring developments also include the Atlas Complex in Marion, Alabama, a medical, pharmaceutical and logistics campus supporting QA/QC, cold-chain logistics, warehousing and domestic distribution. Other updates cover pharmaceutical onshoring initiatives, independent manufacturing oversight, quality-control governance, collaboration activity with life-sciences partners, financial results, investor communications and legal or listing-related corporate matters.
Callan JMB (NASDAQ: CJMB) has announced the pricing of its initial public offering of 1,280,000 shares at $4.00 per share, aiming to raise approximately $5.12 million in gross proceeds before deducting underwriting costs and offering expenses.
The company has granted underwriters a 45-day option to purchase up to an additional 192,000 shares at the public offering price. Trading is expected to begin on the Nasdaq Capital Market on February 5, 2025, under the ticker symbol 'CJMB', with the offering closing around February 6, 2025.
The net proceeds will be used for sales support, marketing, customer expansion, and general corporate purposes, including working capital. Alexander Capital is serving as the managing underwriter, with Paulson Investment Company as joint book-runner.